Lanifibranor
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Lanifibranor, covering 2024-07-09 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) [Phase 3]